The company using MDMA to treat post-traumatic stress, legally

Drug development company Emyria is eyeing a major expansion of its MDMA-assisted post-traumatic stress disorder therapy after getting the green light from regulators to prescribe the world-leading treatment to patients.

More than a century after it was first synthesised, the drug most commonly associated with dance parties and festivals is now showing promising signs in assisting with the treatment of PTSD.